Understand what your gut health results really mean
See your biomarkers in context with a comprehensive panel.
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
How well your microbes turn fiber into fuel
The fiber digestion capacity test analyzes the genetics and activity of the microbes in your stool to estimate how effectively your gut community breaks down dietary fibers. Using modern sequencing approaches, such as 16S rRNA profiling or metagenomics, the test identifies which organisms and fiber‑degrading pathways are present. Some panels also quantify byproducts of fermentation like short‑chain fatty acids (acetate, propionate, and butyrate), which act as fuel for colon cells and as signaling molecules throughout the body. Results describe your current ecosystem and its functional potential, not a permanent trait—microbiomes adapt to what you eat, your environment, and recent medications.
Why this matters: the microbes that digest fiber help regulate motility, keep the gut lining strong, and produce metabolites linked to immune balance and metabolic health. A resilient community typically includes a mix of fiber‑fermenting bacteria that convert plant fibers into SCFAs and other beneficial compounds. While the science is evolving, consistent themes have emerged: higher microbial diversity, steady SCFA production, and the presence of key fermenters are signals of a microbiome that partners well with a fiber‑rich diet. As with any lab, interpretation depends on context and method differences across assays.
What this test helps you understand
Fiber is not one thing—it’s a family of molecules (like inulin, resistant starch, beta‑glucans, and pectins) that your human enzymes can’t break down. Your microbes do the heavy lifting. Testing helps reveal whether your current microbiome is equipped to handle the fibers you eat, and whether fermentation is producing the right balance of outputs. This can illuminate common questions: Why do chickpeas leave me so gassy? Why does oatmeal help one person’s regularity but not another’s? How did that round of antibiotics change my tolerance? It can also clarify what’s happening when you change your diet rapidly, start a high‑fiber regimen, or notice symptoms after switching to a low‑carb plan.
Zoomed out, fiber fermentation influences systems far beyond the gut. SCFAs support the gut barrier, modulate inflammation, and participate in glucose and lipid regulation through gut‑brain and gut‑liver signaling. Observational studies link healthier SCFA profiles with better metabolic markers, though causality is still being mapped. Regular testing lets you see whether your adjustments—more legumes, a different whole grain mix, a new fermented food, or stress‑reduction that smooths gut motility—are nudging your microbiome toward stable, efficient fiber use. The goal is pattern recognition, not perfection: understand your baseline, make informed changes with your care team, and track how your system responds over time.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
Reading your capacity profile
Your report typically compares the abundance of fiber‑digesting organisms and functional pathways to reference populations, and may include levels or relative patterns of fermentation products. “Balanced” profiles often show higher diversity with representation of beneficial fermenters—such as Bifidobacterium, Faecalibacterium, and Roseburia—and evidence of multiple routes for producing SCFAs. Lower diversity or dominance of a few gas‑heavy species can suggest an imbalanced fermentation pattern.
When results lean toward “optimal,” you tend to see signs of efficient fiber breakdown: steady SCFA potential (especially butyrate, a preferred fuel for colon cells), lower inflammatory signaling in the gut environment, and markers of a sturdy barrier. In lived experience, that often correlates with regular bowel habits and less dramatic swings in post‑meal energy. “Optimal” is individualized—genetics, geography, and habitual diet all shape what’s normal for you.
When results suggest dysbiosis, you may see reduced diversity, lower predicted capacity for SCFA production, loss of key fermenters, or patterns associated with gas and bloating. These are not diagnoses; they highlight functional trends that can be explored through nutrition strategies (for example, titrating fiber types or adding prebiotic‑rich foods), or medical evaluation if symptoms persist. If you’re using GLP‑1–based therapies or have had recent antibiotic exposure, interpretation will account for shifts in motility and microbial composition.
What capacity testing can and can't tell you
Big picture, fiber digestion findings are most useful alongside other biomarkers—like stool inflammatory markers, glucose and lipid panels, or immune measures—and interpreted over time. Because stool testing captures a snapshot of luminal microbes and can be influenced by recent meals, illness, colonoscopy prep, or sample handling, trends and clinical context matter. Different labs use different sequencing and reporting methods, so ranges and pathway labels may vary. Taken together with your history, diet, and goals, this test can help personalize how you use fiber to support digestion, energy, and long‑term metabolic resilience.
Frequently Asked Questions
References
- Makki K, Deehan EC, Walter J, Bäckhed F (2018). The impact of dietary fiber on gut microbiota in host health and disease. *Cell Host & Microbe*, *23*(6), 705-715. https://doi.org/10.1016/j.chom.2018.05.012
- Parada Venegas D, De la Fuente MK, Landskron G, González MJ, Quera R, Dijkstra G, Harmsen HJM, Faber KN, Hermoso MA (2019). Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. *Frontiers in Immunology*, *10*, 277. https://doi.org/10.3389/fimmu.2019.00277
- Afzaal M, Saeed F, Shah YA, Hussain M, Rabail R, Socol CT, Hassoun A, Pateiro M, Lorenzo JM, Rusu AV, Aadil RM (2022). Human gut microbiota in health and disease: Unveiling the relationship. *Frontiers in Microbiology*, *13*, 999001. https://doi.org/10.3389/fmicb.2022.999001
- Laudadio I, Fulci V, Palone F, Stronati L, Cucchiara S, Carissimi C (2018). Quantitative assessment of shotgun metagenomics and 16S rDNA amplicon sequencing in the study of human gut microbiome. *OMICS*, *22*(4), 248-254. https://doi.org/10.1089/omi.2018.0013
- Porcari S, Mullish BH, Asnicar F, Ng SC, Zhao L, Hansen R, O'Toole PW, Raes J, Hold G, Putignani L, Hvas CL, Nieuwdorp M, Sokol H, Ianiro G, Cammarota G (2025). International consensus statement on microbiome testing in clinical practice. *The Lancet Gastroenterology & Hepatology*, *10*(2), 154-167. https://doi.org/10.1016/S2468-1253(24)00311-X















